FDA Approval Activities for this Drug
Metoclopramide Solution USP, 5 mg/5 mL, UDL , ANDA 75-051 Reglan (metoclopramide) Tablets, Injection, and Syrup, A.H. Robins
c/o: Wyeth-Ayerst Research Reglan (metoclopramide, USP) Tablets, Schwartz Pharma, Labeling Revision
NDA 17-854/S-041,
& 17-862/S-048,
& 18-821/S-020 11/7/01 11/25/02
Reglan (metoclopramide) Tablets, Schwartz Pharma, NDA 17-854/S-040 4/22/03
Reglan (metoclopramide) Tablets, Injection, & Syrup, Wyeth-Ayerst NDA 17-854/S039, 17-862/S042, & 18-821/S018 Reglan (metoclopramide) Injection, Baxter Healthcare | Metoclopramide Orally Disintegrating Tablets, Schwarz Pharma, Approval | Metoclopramide Tablets, Vintage Pharmaceuticals, Approval | Metoclopramide Tablets, Northstar Healthcare, Approval
| Metoclopramide Hydrochloride Tablets, Ipca Laboratories, Ltd., Approval